SANFORD H. ROTH, M.D.
To the editor: The Anti-Rheumatic New Drug Guidelines Group, first described in an Annals' editorial in July 1984 (1), has now submitted recommendations to the Food and Drug Administration (FDA) that will be reported at the second annual meeting of this group in Scottsdale, Arizona, on 1 to 3 May 1986. This meeting will be held in parallel and simultaneously with a national symposium on rheumatic therapeutics. This will allow for open participation and response to the outcomes of this continuing process, which happily will be in concert with a program of extensive discussions on the panoply of therapies in
ROTH SH. Guidelines on New Anti-Rheumatic Drugs. Ann Intern Med. ;104:288. doi: 10.7326/0003-4819-104-2-288_1
Download citation file:
Published: Ann Intern Med. 1986;104(2):288.
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use